The future of antiviral therapies looks promising with advancements in technology and a better understanding of virology. Innovations such as CRISPR-based gene editing, monoclonal antibodies, and novel drug delivery systems are being explored. Personalized medicine, which tailors treatments based on individual genetic profiles, could also enhance the efficacy of antiviral therapies. Ongoing research and global collaboration are essential to overcoming the challenges and improving the arsenal of tools available to combat viral infections.
